Bad news and good news in AD, and how to reconcile them

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

2018 saw the failure of several large clinical trials that were based on the premise that reduction of amyloid-β levels is an effective treatment for symptomatic Alzheimer disease. Yet, over the same time period, good news also emerged about the diagnostic value of tau PET imaging.

Original languageEnglish (US)
JournalNature Reviews Neurology
DOIs
StateAccepted/In press - Jan 1 2019

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Bad news and good news in AD, and how to reconcile them'. Together they form a unique fingerprint.

  • Cite this